Factor V Leiden Mutation Accompanying Recurrent Massive Pulmonary Thromboembolism

被引:0
作者
Perincek, Gokhan [1 ]
Hatipoglu, Osman Nuri [2 ]
Ege, Turan [3 ]
Kara, Ibrahim [4 ]
Kul, Seref [5 ]
机构
[1] Hakkari Devlet Hastanesi, Gogus Hastaliklari Bolumu, Hakkari, Turkey
[2] Trakya Univ, Tip Fak, Gogus Hastaliklari Bolumu, Edirne, Turkey
[3] Trakya Univ, Tip Fak, Kalp & Damar Cerrahisi Bolumu, Edirne, Turkey
[4] Hakkari Devlet Hastanesi, Kalp & Damar Cerrahisi Bolumu, Hakkari, Turkey
[5] Hakkari Devlet Hastanesi, Kardiyol Bolumu, Hakkari, Turkey
关键词
Factor V Leiden; pulmonary thromboembolism; vena cava filters;
D O I
暂无
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
A 46-year-old female patient was admitted to the emergency department with the complaints of dyspnea, swelling of the right leg and and feeling of unwell. Deep venous thrombosis was detected at the lower extremity venous Doppler ultrasound and thrombi was detected at the left main pulmonary artery and at the segmental pulmonary arteries bilaterally with the computed tomography of thorax. As hypotension was developed, she was diagnosed with pulmonary thromboembolism and treated with streptokinase infusion. The patient's complaint of dyspnea decreased and her haemodynamic parameters improved after thrombolytic therapy, and subsequently she underwent anticoagulant therapy. On the fifth day of monotorization, while still under the anticoagulant therapy, the patient suddenly developed dyspnea, cyanosis and hypotension. The rt-PA therapy was adminestered with the pre-diagnosis of recurrent massive pulmonary thromboembolism. After the rt-PA therapy, the patient's haemodynamics improved, her cyanosis and complaints of dyspnea regressed. Heterozygote Factor V Leiden mutation was detected with examinations. Inferior vena cava filter was placed together with the anticoagulant therapy. The patient has been under our monitoring for 3 months.
引用
收藏
页码:51 / 54
页数:4
相关论文
共 9 条
[1]  
Akbal E, 2009, ERCIYES MED J, V31, P344
[2]  
Akpinar B, 2007, AKAD ACIL TIP DEGISI, V3, P26
[3]  
Altintas A, 2007, UHOD-ULUSLAR HEMATOL, V2, P65
[4]  
Bayir A, 2003, GENEL TIP DERG, V13, P81
[5]  
Ferrari E, 1997, EUR HEART J, V18, P685
[6]  
Karadag F, 2001, AKCIGER ARSIVI, V2, P85
[7]   Guidelines for the use of retrievable and convertible vena cava filters: Report from the Society of Interventional Radiology multidisciplinary consensus conference [J].
Kaufman, JA ;
Kinney, TB ;
Streiff, MB ;
Sing, RF ;
Proctor, MC ;
Becker, D ;
Cipolle, M ;
Comerota, AJ ;
Millward, SF ;
Rogers, FB ;
Sacks, D ;
Venbrux, AC .
JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY, 2006, 17 (03) :449-459
[8]  
Oner Ferda, 2003, Tuberk Toraks, V51, P60
[9]  
Unluer EE, 2002, SOLUNUM HASTALIKLARI, V13, P67